Biogen Inc. vs Divi's Laboratories Limited
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Biogen Inc. is the larger company by market value: $37.5 B against $32.0 B for Divi's Laboratories Limited, 1.2 times as much (market caps of Oct 23, 2026 for Biogen Inc. and Nov 20, 2026 for Divi's Laboratories Limited).
- Biogen Inc. had more revenue: $9.9 B in the year to December 2025 against $1.1 B for Divi's Laboratories Limited in the year to March 2026.
- Biogen Inc. earned more: net income of $1.3 B against $277 M for Divi's Laboratories Limited.
- Divi's Laboratories Limited keeps more of each dollar of sales: a net margin of 24.5% against 13.1% for Biogen Inc.
- Divi's Laboratories Limited employs more people: 13,884 against 7,500 at Biogen Inc. Each employee brings in about $1,318,747 of revenue at Biogen Inc. and $81,473 at Divi's Laboratories Limited.
- On price to earnings, Divi's Laboratories Limited trades at 115.5× and Biogen Inc. at 108.0×: investors pay more for each dollar of Divi's Laboratories Limited's profit.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Biogen Inc. BIIB · #692 in the world | Divi's Laboratories Limited DIVISLAB.NS · #802 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇮🇳 India |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 1978 | 1990 |
| Size | ||
| Market cap | $37.5 B | $32.0 B |
| Revenue | $9.9 B | $1.1 B |
| Net income | $1.3 B▲ best | $277 M |
| Employees | 7,500 | 13,884 |
| Valuation | ||
| P/E ratio | 108× | 115× |
| Price to sales | 3.6× | 28.3× |
| Price to book | 2.1× | 17.7× |
| Free cash flow yield | 5.5% | — |
| Profitability | ||
| Gross margin | 75.7% | — |
| Net margin | 13.1% | — |
| Return on equity | 7.4% | — |
| Growth | ||
| Revenue growth | 2.2% | — |
| Revenue growth, 3 years a year | -0.9% | — |
| Earnings per share growth | -21.4% | — |
| Financial strength | ||
| Debt to equity | 0.3× | — |
| Cash | ||
| Free cash flow margin | 20.7% | — |
| Strength scores | ||
| Piotroski F-score | 4 of 9 | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Nov 2026 |
Questions and answers#
Which is bigger, Biogen Inc. or Divi's Laboratories Limited?
Biogen Inc. is the larger company by market value: $37.5 B against $32.0 B for Divi's Laboratories Limited, 1.2 times as much (market caps of Oct 23, 2026 for Biogen Inc. and Nov 20, 2026 for Divi's Laboratories Limited).
Which makes more money, Biogen Inc. or Divi's Laboratories Limited?
Biogen Inc. had more revenue: $9.9 B in the year to December 2025 against $1.1 B for Divi's Laboratories Limited in the year to March 2026. Biogen Inc. earned more: net income of $1.3 B against $277 M for Divi's Laboratories Limited.
Which is more profitable, Biogen Inc. or Divi's Laboratories Limited?
Divi's Laboratories Limited keeps more of each dollar of sales: a net margin of 24.5% against 13.1% for Biogen Inc.
Which has more employees, Biogen Inc. or Divi's Laboratories Limited?
Divi's Laboratories Limited employs more people: 13,884 against 7,500 at Biogen Inc. Each employee brings in about $1,318,747 of revenue at Biogen Inc. and $81,473 at Divi's Laboratories Limited.
Is Biogen Inc. cheaper than Divi's Laboratories Limited?
On price to earnings, Divi's Laboratories Limited trades at 115.5× and Biogen Inc. at 108.0×: investors pay more for each dollar of Divi's Laboratories Limited's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.